{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/brain-central-nervous-system-cancers-recognition-referral/goals-outcome-measures/qof-indicators/","result":{"pageContext":{"chapter":{"id":"e146f3c2-1c19-509f-87a6-7d38b4f9e0eb","slug":"qof-indicators","fullItemName":"QOF indicators","depth":2,"htmlHeader":"<!-- begin field d5b0a5c0-fcf7-4d65-a8b4-bf2721c27644 --><h2>QOF indicators</h2><!-- end field d5b0a5c0-fcf7-4d65-a8b4-bf2721c27644 -->","summary":null,"htmlStringContent":"<!-- begin item 2888072f-43c3-49bc-90d9-e7ffad3f6f53 --><!-- begin field 6520d4fd-9a7c-4398-8d3b-203fe18e6a1e --><p><strong>Table 1.</strong> Indicators related to cancer in the Quality and Outcomes Framework (QOF) of the General Medical Services (GMS) contract.</p><table data-table-id=\"7a1afef5-4446-4c7d-9839-acce014ee954\"><thead><tr><th colspan=\"1\">Indicator</th><th colspan=\"1\">Points</th><th colspan=\"1\">Achievement thresholds</th></tr></thead><tbody><tr><td colspan=\"1\"><strong>CAN001.</strong> The contractor establishes and maintains a register of all cancer patients defined as a ‘register of patients with a diagnosis of cancer excluding non-melanotic skin cancers diagnosed on or after 1 April 2003’</td><td colspan=\"1\">5</td><td colspan=\"1\"> </td></tr><tr><td colspan=\"1\"><strong>CAN003.</strong> The percentage of patients with cancer, diagnosed within the preceding 15 months, who have a patient review recorded as occurring within 6 months of the date of diagnosis</td><td colspan=\"1\">6</td><td colspan=\"1\">50–90%</td></tr><tr><td colspan=\"3\"><strong>Data from:</strong> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/brain-central-nervous-system-cancers-recognition-referral/references/\">BMA and NHS England, 2019</a>]</td></tr></tbody></table><!-- end field 6520d4fd-9a7c-4398-8d3b-203fe18e6a1e --><!-- end item 2888072f-43c3-49bc-90d9-e7ffad3f6f53 -->","topic":{"id":"aa7cf861-d312-5f9c-86ef-a46404a6f544","topicId":"6fc8f65b-ae32-4117-b08f-c714436d9403","topicName":"Brain and central nervous system cancers - recognition and referral","slug":"brain-central-nervous-system-cancers-recognition-referral","lastRevised":"Last revised in February 2021","chapters":[{"id":"e241e306-2458-5047-b18e-04b7d1fc2308","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"3e1b523e-802f-58de-a332-1868d978577a","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"b68b72e1-89aa-5c6a-92a3-d72bd73b56f6","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"e73e1351-a28e-5811-abad-28d0d4989725","slug":"changes","fullItemName":"Changes"},{"id":"2b475829-0c45-5f23-ab82-f08233292c44","slug":"update","fullItemName":"Update"}]},{"id":"4405d39e-d989-59c5-9127-971bdd0b3f33","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"2613adb1-3736-5189-9855-1803ca32a172","slug":"goals","fullItemName":"Goals"},{"id":"11fcd25d-dbb9-5286-9eae-3173b17e9850","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"1ba691bf-0bda-5dfa-8afc-e1f6692e790c","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"e146f3c2-1c19-509f-87a6-7d38b4f9e0eb","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"085b6bc0-3c13-5587-8bea-85e542ae42bc","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"f912aebb-aa1c-5029-9984-a51140aba62d","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"7ca2c136-9221-5fa0-a1bf-7d0715135714","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"db1a1f8a-b6a1-58ee-93d8-e2d4b048e973","slug":"presentation","fullItemName":"Presentation"},{"id":"3d0beb7e-65f2-5281-9ace-04c774d52b07","slug":"prevalence","fullItemName":"Prevalence"},{"id":"ed9c2f5c-3ec5-5aa7-97e7-a095f80b25c8","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"4da46716-ea51-55f1-b22b-95a3c7cf364d","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"50b91796-121b-529d-b990-87de3adad136","slug":"symptoms-suggestive-of-brain-central-nervous-system-cancers","fullItemName":"Symptoms suggestive of  brain and central nervous system cancers"}]},{"id":"255d4f66-3f39-54d0-a05a-2940a6d2d862","fullItemName":"Management","slug":"management","subChapters":[{"id":"14e235d4-0ccc-5edb-a98e-2ddfe2f3488b","slug":"referral-for-brain-central-nervous-system-cancers","fullItemName":"Scenario: Referral for brain and central nervous system cancers"}]},{"id":"c458475d-a110-5b4d-a10b-26597f233810","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"58c7662a-95b3-5150-acab-eab30f9116e7","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"62e8986e-c4fe-5d3f-be5e-233510c69f16","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"61615106-28fd-5b4f-9cae-c5d20bd4703f","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"8f761a7b-1c43-591b-ad75-1939c5b32336","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"724028ec-2cdc-5a2f-b03e-645008121d6f","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"5cefc717-086c-5aaf-af4b-a7d3d3cb04c1","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"6d75f2af-1613-5be8-b4f8-36a7a73ba607","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"4405d39e-d989-59c5-9127-971bdd0b3f33","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures"},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}